Pearl IRB is pleased to announce that we have joined SMART IRB, a platform to ease common challenges and burdens associated with initiating multisite research. SMART IRB is a collaborative initiative supported by the National Center for Advancing Translational Sciences (NCATS) and led by Harvard Catalyst, University of Wisconsin-Madison ICTR, and Dartmouth Synergy.
Shaping the future of multisite research
Through a flexible master IRB reliance agreement, standard operating procedures, and complementary tools and resources, SMART IRB supports and encourages collaboration and harmonization across a national consortium of institutions. Together with SMART IRB, we will shape the future of multisite research across the nation, creating a network that will foster and enhance collaboration.
Pearl IRB strives to deliver superior independent review board services to improve the clinical research process thereby delivering new therapeutics and diagnostics to patients sooner.
The goal of SMART IRB is to streamline the IRB review process in multisite research, help investigators obtain trial results faster and, ultimately, advance the development of new diagnostics, treatments, and preventative measures for patients, while maintaining strong human research protections, oversight, and regulatory compliance.
Under the SMART IRB Agreement, investigators conducting multisite research may request that participating institutions rely on the review of a single IRB, and institutions may elect to do so on a study-by-study basis.
For information about how you can leverage Pearl IRB’s new technology platform for your multisite research, please contact us today.